Monday is kicking off a very important week in the markets, with earnings season on the horizon and the first presidential debate later in the evening. Biotech and pharmaceutical companies have been at the forefront of the discussion recently, and a favorite target of Hillary Clinton. Just as she has sent the industry into a panic before by only tweeting about drug pricing, Monday night will offer her a platform to expand on her opinions and beliefs. Who knows where the industry could go from here?
24/7 Wall St. has picked out some of the major companies in the health care sector that are moving ahead of the debate and added in some color for each, as well as a recent trading history, consensus analyst price target, and 52-week range.
Shares of Array BioPharma Inc. (NASDAQ: ARRY) saw a handy gain early in Monday’s session after the company announced top-line results from